Kowalski Mark
Insider CIK 1628357 · DNAI Chief, Research & Early Dev · ABUS Sr VP & Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRA Sierra Oncology, Inc. | A Award deriv | 2022-01-28 | 2022-01-28 | 12,250 | — | $0 | 12,250 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2021-03-15 | 2021-03-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-08-12 | 2020-08-12 | 24,970 | — | $0 | 24,970 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 75,030 | — | $0 | 75,030 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2019-03-04 | 2019-03-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2018-03-06 | 2018-03-07 | 155,000 | — | $0 | 155,000 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | A Award deriv | 2017-01-03 | 2017-01-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2016-03-15 | 2016-03-17 | 85,000 | — | $0 | 85,000 | SEC↗ |